Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Clinical manifestations of patients with CASPR2 antibodies

(2015) Jun-Sang Sunwoo et al.   JOURNAL OF NEUROIMMUNOLOGY

Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica

(2015) Sarosh R. Irani et al.   JAMA Neurology

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

(2015) Marius Ringelstein et al.   JAMA Neurology

Cell-surface central nervous system autoantibodies: Clinical relevance and emerging paradigms

(2014) Sarosh R. Irani et al.   ANNALS OF NEUROLOGY

Autoimmune encephalitis as differential diagnosis of infectious encephalitis

(2014) Thaís Armangue et al.   CURRENT OPINION IN NEUROLOGY

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Korea: Clinical Features, Treatment, and Outcome

(2014) Jung-Ah Lim et al.   Journal of Clinical Neurology

Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis

(2014) Tae-Joon Kim et al.   JOURNAL OF NEUROIMMUNOLOGY

The spectrum of acute encephalitis: Causes, management, and predictors of outcome

(2014) T. D. Singh et al.   NEUROLOGY

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

(2014) R. C. Dale et al.   NEUROLOGY

Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study

(2014) M. Araki et al.   NEUROLOGY

Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium

(2013) A. Venkatesan et al.   CLINICAL INFECTIOUS DISEASES

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy

(2013) Ilya Ayzenberg et al.   JAMA Neurology

Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab

(2013) Christos Krogias et al.   JAMA Neurology

The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project

(2012) M. S. Gable et al.   CLINICAL INFECTIOUS DISEASES

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

(2012) Y. Hacohen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

(2011) Toshio Tanaka et al.   FEBS LETTERS

Encephalitis and antibodies to synaptic and neuronal cell surface proteins

(2011) E. Lancaster et al.   NEUROLOGY

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

(2010) Gabor G. Illei et al.   ARTHRITIS AND RHEUMATISM

IL-6: Regulator of Treg/Th17 balance

(2010) Akihiro Kimura et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

(2010) S. J. Kim et al.   HAEMATOLOGICA

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

(2008) N Nishimoto et al.   ANNALS OF THE RHEUMATIC DISEASES

The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2008) Allan R. Tunkel et al.   CLINICAL INFECTIOUS DISEASES

Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction

(2008) Hideki Ogura et al.   IMMUNITY

A review of the current use of rituximab in autoimmune diseases

(2008) Hakan M. Gürcan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

(2008) Josef S Smolen et al.   LANCET